1. Home
  2. TBPH vs MOMO Comparison

TBPH vs MOMO Comparison

Compare TBPH & MOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

N/A

Current Price

$19.26

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Logo Hello Group Inc.

MOMO

Hello Group Inc.

N/A

Current Price

$6.48

Market Cap

1.1B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
TBPH
MOMO
Founded
2013
2011
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
TBPH
MOMO
Price
$19.26
$6.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$27.80
$13.00
AVG Volume (30 Days)
386.5K
662.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
4.53%
EPS Growth
N/A
N/A
EPS
0.88
N/A
Revenue
$15,386,000.00
N/A
Revenue This Year
$70.90
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$21.66
$10.60
Revenue Growth
N/A
N/A
52 Week Low
$7.90
$5.13
52 Week High
$21.03
$9.22

Technical Indicators

Market Signals
Indicator
TBPH
MOMO
Relative Strength Index (RSI) 45.07 43.40
Support Level $18.27 $6.39
Resistance Level $19.04 $7.14
Average True Range (ATR) 0.91 0.15
MACD -0.09 0.01
Stochastic Oscillator 23.72 33.66

Price Performance

Historical Comparison
TBPH
MOMO

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About MOMO Hello Group Inc.

Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.

Share on Social Networks: